Cookies on this site

Research led by the University of Oxford, and funded by Cancer Research UK, has found the strongest evidence yet that e-cigarettes, also known as ‘vapes’, help people to quit smoking better than traditional nicotine replacement therapies, such as patches and chewing gums.

Close-up of someone applying a nicotine patch to their arm © Shutterstock

New evidence published today in the Cochrane Library finds high certainty evidence that people are more likely to stop smoking for at least six months using nicotine e-cigarettes, or ‘vapes’, than using nicotine replacement therapies, such as patches and gums. Evidence also suggested that nicotine e-cigarettes led to higher quit rates than e-cigarettes without nicotine, or no stop smoking intervention, but less data contributed to these analyses. The updated Cochrane review includes 78 studies in over 22,000 participants – an addition of 22 studies since the last update in 2021.

Smoking is a significant global health problem. According to the World Health Organisation (WHO), in 2020, 22.3% of the global population used tobacco, despite it killing up to half of its users. Stopping smoking reduces the risk of lung cancer, heart attacks and many other diseases. Though most people who smoke want to quit, many find it difficult to do so permanently. Nicotine patches and gum are safe, effective and widely used methods to help individuals quit.

E-cigarettes heat liquids with nicotine and flavourings, allowing users to ‘vape’ nicotine instead of smoking. Data from the review showed that if six in 100 people quit by using nicotine replacement therapy, eight to twelve would quit by using electronic cigarettes containing nicotine. This means an additional two to six people in 100 could potentially quit smoking with nicotine containing electronic cigarettes.

Misunderstanding discourage some people from using e-cigarettes as a stop smoking tool. Fortunately, more and more evidence is emerging and provides further clarity. With support from Cancer Research UK, we search for new evidence from the most reliable scientific studies every month as part of a living systematic review. For the first time, this has given us high-certainty evidence that e-cigarettes are even more effective at helping people to quit smoking than traditional nicotine replacement therapies.- Dr Jamie Hartmann-Boyce, Associate Professor at the University of Oxford, Editor of the Cochrane Tobacco Addiction Group and an author of the new publication 

In studies comparing nicotine e-cigarettes to nicotine replacement treatment, significant side effects were rare. In the short-to-medium term (up to two years), nicotine e-cigarettes most typically caused throat or mouth irritation, headache, cough, and feeling nauseous. However, these effects appeared to diminish over time.

Dr Nicola Lindson, University Research Lecturer at the University of Oxford, Cochrane Tobacco Addiction Group’s Managing Editor, and author of the publication said:

“E-cigarettes do not burn tobacco; and as such they do not expose users to the same complex mix of chemicals that cause diseases in people smoking conventional cigarettes. E-cigarettes are not risk free, and shouldn’t be used by people who don’t smoke or aren’t at risk of smoking. However, evidence shows that nicotine e-cigarettes carry only a small fraction of the risk of smoking. In our review, we did not find evidence of substantial harms caused by nicotine containing electronic cigarettes when used to quit smoking. However, due to the small number of studies and lack of data on long-term nicotine-containing electronic cigarette usage – usage over more than two years – questions remain about long-term effects.”

The researchers conclude that more evidence, particularly about the effects of newer e-cigarettes with better nicotine delivery than earlier ones, is needed to assist more people quit smoking. Longer-term data is also needed.

Michelle Mitchell, chief executive at Cancer Research UK, said: “We welcome this report which adds to a growing body of evidence showing that e-cigarettes are an effective smoking cessation tool. We strongly discourage those who have never smoked from using e-cigarettes, especially young people. This is because they are a relatively new product and we don’t yet know the long term health effects.“

“While the long term effects of vaping are still unknown, the harmful effects of smoking are indisputable – smoking causes around 55,000 cancer deaths in the UK every year. Cancer Research UK supports balanced evidence-based regulation on e-cigarettes from UK governments which maximises their potential to help people stop smoking, whilst minimising the risk of uptake among others.”

This work was supported by Cancer Research UK [A ref. A29845]

This study is published in the Cochrane Library.

Similar stories

The Glastonbury of EBM inspires and showcases the next generation of EBM leaders

The mission of this year’s EBMLive, the 11th major evidence-live themed conference since the inaugural event in 2011, was to offer a platform that encouraged debate and learning on the current status and future directions of Evidence-Based Medicine (EBM), actively disseminating and translating evidence in health care. Was this mission accomplished?

Oxford Medical Students publish new findings through CEBM training

Oxford Medical Students who participated in the Centre for Evidence-Based Medicine’s Special Study Theme (SST) have published new findings in a peer-reviewed journal, demonstrating the strength of the programme in equipping undergraduates to produce high-quality, clinically relevant research.

Preventing Overdiagnosis (POD) Conference 2025

Highlights and key takeaways from our gathering of global expertise in Oxford, building on the momentum of previous conferences since the first small gathering in 2012.

Professor Carl Heneghan presents evidence on the health impacts of breast implants at UK parliamentary Women and Equalities Committee

Professor Carl Heneghan, Director of the Centre for Evidence-Based Medicine and co-Director of the DPhil in Evidence-Based Health Care at Oxford University joined other academics and medical professionals to provide evidence on the health impacts of breast implants during a Women and Equalities Committee (WEC) all evidence session in Parliament on Wednesday, 14 May 2025.

Members of CEBM and the Oxford Tobacco Addiction Group (OxTAG) share their work at key conference in New Orleans.

CEBM members and affiliates who are part of the Oxford Tobacco Addiction Group team (OxTAG) shared their smoking/vaping cessation research work at the annual Society for Research on Nicotine and Tobacco (SRNT) conference in New Orleans earlier this month.

New study identifies text messaging and varenicline as promising approaches for vaping cessation

With 5.1 million people in Great Britain using vapes, what support is there to help people quit? New research explores the best interventions currently available.